From here to eternity: a unified kinetic model for the pathophysiology of atherosclerotic events
Related Experiment Video
Updated: Jul 17, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
George A Diamond1, Sanjay Kaul
1Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, Calif, USA. gadiamond@pol.net
Insights
This study unifies physical and biochemical models of ischemic heart disease into a kinetic model. It suggests cardiovascular events arise from transitions between inflammatory and stenotic states, impacting treatment strategies.
Area of Science:
- Cardiovascular Pathophysiology
- Biomedical Modeling
Background:
- Ischemic heart disease management relies on two models: physical (vascular stenosis) and biochemical (plaque inflammation).
- These models are often seen as competing, influencing interventional versus conservative treatment approaches.
Purpose of the Study:
- To unify the physical and biochemical models of ischemic heart disease pathophysiology.
- To develop a kinetic model characterizing cardiovascular events as transitions between inflammatory and stenotic states.
- To provide a theoretical basis for predicting event causes and prevention strategies.
Main Methods:
- Developed a kinetic model representing transitions between non-stenotic/non-inflammatory, inflammatory, and stenotic states.
- Modeled the exponential changes in prevalence of these states over time.
- Formulated event rate as a function of myocardial ischemia and vascular inflammation.
Main Results:
- The model describes a decline in the normative state and a rise-then-fall pattern for inflammatory and stenotic states.
- Cardiovascular event rates increase as a complex function of both ischemia and inflammation.
- The model offers a framework to differentiate contributions of stenosis and inflammation to atherosclerotic events.
Conclusions:
- The unified kinetic model reconciles competing perspectives in ischemic heart disease management.
- It provides a theoretical foundation for personalized prevention strategies targeting plaque stabilization or ischemia relief.
- Further prospective validation is needed to confirm the model's predictive capabilities.
Abstract:
Two operative pathophysiological models underlie the clinical management of ischemic heart disease: a physical model founded on the magnitude of vascular stenosis and a biochemical model founded on the inflammatory processes within the atherosclerotic plaque. Despite their complementary natures, these 2 models are implicitly competitive--the stenotic model supporting the primacy of aggressive interventional procedures and the inflammatory model supporting the primacy of conservative medical management. We unified these alternative perspectives through a kinetic model that characterizes the pathophysiology of cardiovascular events as a network of exponential transitions between the inflammatory and stenotic states. According to this model, the prevalence of the normative (nonstenotic and noninflammatory) state falls exponentially, while the prevalences of the inflammatory and stenotic states rise to a peak and then fall off exponentially. According to this model, event rate increases as a complex function of both myocardial ischemia and vascular inflammation. Although the model has yet to be prospectively validated, it provides a theoretical foundation for predicting the degree to which atherosclerotic events are due to inflammation versus stenosis and the degree to which they can thereby be prevented by treatment strategies directed at plaque stabilization or relief of ischemia.
More Related Videos
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
09:14The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
Published on: October 3, 2017
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Atherosclerosis III: Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests